German Parliament Debates Prenatal Tests - Motion Calls for Broader Data Basis - Germany debates stricter oversight for prenatal genetic testing amid ethical concerns

The German Parliament has debated stricter rules on non-invasive prenatal tests (NIPT). Over 100 lawmakers from different parties pushed for clearer regulations on how these genetic blood tests are used. Concerns were raised about false-positive results and the emotional strain they place on expectant parents.

NIPT screens for trisomies 13, 18, and 21, with Down syndrome (trisomy 21) being the most common condition detected. Despite the test's availability, lawmakers noted that invasive procedures, which carry higher risks, have not decreased.

The proposed motion calls for a monitoring system to collect better data on NIPT usage and outcomes. It also suggests forming an expert panel to examine the legal, ethical, and health policy effects of public insurance covering these tests. SPD lawmaker Dagmar Schmidt stressed the importance of informed choices and opposed routine testing for trisomy 21.

CSU lawmaker Emmi Zeulner explained that the goal was to improve transparency and knowledge around prenatal testing. The motion aims to prevent NIPT from becoming a standard procedure while ensuring parents receive balanced information before making decisions.

If approved, the new rules would introduce stricter oversight of NIPT administration. The expert panel would review broader implications, including ethical concerns and insurance policies. The debate reflects growing calls for caution in how genetic testing is integrated into prenatal care.